Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Resolution Therapeutics Logo
Resolution Therapeutics Growth Score
75
CB Rank
19642
Heat Score
62
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Founded
obfuscation
PrivateSeries B London, England, United Kingdom51-100 resolution-tx.com
Biopharma
Biotechnology
Life Science
Overview

Resolution Therapeutics
Total Funding
obfuscation
Growth Score
75
Heat Score
62

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score75
-1 pts
in past quarter
Heat Score 62
5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Resolution Therapeutics

CB Rank
19642
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Founded
obfuscation
PrivateSeries B London, England, United Kingdom51-100 resolution-tx.com
Biopharma
Biotechnology
Life Science

Funding Rounds

Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

  • Photo of Amir Hefni
    Amir Hefni: Chief Executive Officer
    Past Role: Ipsen, Vice President of Global Asset Head and Oncology
  • Photo of Simon Ramsden
    Simon Ramsden: CFO
    Past Role: Closed Loop Medicine, Chief Financial Officer

Details

Legal Name Resolution Therapeutics Ltd
Operating Status Active
Company Type For Profit
Founders  John Campbell, Stuart Forbes
About the Company
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Predictions & Insights

Growth Insight

See this Growth Insight
Resolution Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

RTX001
An engineered autologous macrophage cell therapy designed to enhance anti-fibrotic and anti-inflammatory effects for treating end-stage liver disease.
MATCH Trial
A clinical trial investigating the safety and efficacy of autologous macrophage cell therapy in patients with liver cirrhosis.

Research & Development

Resolution Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Resolution Therapeutics Logo
Series B - Resolution Therapeutics
1
obfuscation
— Series B
obfuscation
Series B - Resolution Therapeutics Logo
Series B - Resolution Therapeutics
1
obfuscation
— Series B
obfuscation
Series B - Resolution Therapeutics Logo
Series B - Resolution Therapeutics
1
obfuscation
— Series B
obfuscation
Series B - Resolution Therapeutics Logo
Series B - Resolution Therapeutics
1
obfuscation
— Series B
obfuscation
Series B - Resolution Therapeutics Logo
Series B - Resolution Therapeutics
1
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Resolution Therapeutics Logo
Series B - Resolution Therapeutics
1
obfuscation
— Series B
obfuscation
Series B - Resolution Therapeutics Logo
Series B - Resolution Therapeutics
1
obfuscation
— Series B
obfuscation
Series B - Resolution Therapeutics Logo
Series B - Resolution Therapeutics
1
obfuscation
— Series B
obfuscation
Series B - Resolution Therapeutics Logo
Series B - Resolution Therapeutics
1
obfuscation
— Series B
obfuscation
Series B - Resolution Therapeutics Logo
Series B - Resolution Therapeutics
1
obfuscation
— Series B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 5 Board Members and Advisors 9 Contacts 38

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 26, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,221
70.32%
 in past month

IT Spend

$69.6KThis year, Resolution Therapeutics is projected to spend $69.6K on IT, according to Aberdeen.

Active Website Tech Count

39Resolution Therapeutics is actively using 39 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.

Total IP

7The intellectual property of Resolution Therapeutics includes 5 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery. Additionally, Resolution Therapeutics has registered 2 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Resolution Therapeutics's headquarters? Resolution Therapeutics is located in London, England, United Kingdom.Who invested in Resolution Therapeutics? Resolution Therapeutics has 2 investors including Syncona Partners LLP and  Syncona Partners LLP.When was the last funding round for Resolution Therapeutics? Resolution Therapeutics closed its last funding round on
obfuscation
from a Series B round.Who are Resolution Therapeutics's competitors? Alternatives and possible competitors to Resolution Therapeutics may include Carisma Therapeutics, Mesoblast, and  Cynata.How much funding has Resolution Therapeutics raised to date? Resolution Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b4ae374 1)
|